// company-profile

MiNK Therapeutics, Inc.

INKT
ExchangeNasdaqSectorBiological Products, (No Diagnostic Substances)Inc.DEFilings96Insiders11
// api This MiNK Therapeutics, Inc. insider-trading data is served live by the Form4API insider trading API. Get the same data via API.

// activity-summary

Recent insider activity is bullish. Over the last 30 days, 5 insiders purchased shares (net $60K) versus 2 sales. Buying was led by Corvese Brian.

// 90-day insight

Over the last 90 days, MiNK Therapeutics, Inc. insiders bought $79K (5 transactions) and sold $19K (2 transactions).

  • Most active insider: Ryan Barbara with 3 transactions totaling $37K.
  • Largest single purchase: $18K by Corvese Brian on Jun 1, 2026.

Activity skews bullish — buys outpace sales.

Institutional Ownership

Top 13F-HR holders of MiNK Therapeutics, Inc. as of 2026-03-31

↓ decreasing
Total reported AUM
$1.2M
QoQ change
-23.9%
Reporting period
2026-03-31
#1
VANGUARD CAPITAL MANAGEMENT LLC
CIK 2100119
$625,103
59K shares
#2
Longbow Finance SA
CIK 1965552
$175,504
17K shares
#3
GEODE CAPITAL MANAGEMENT, LLC
CIK 1214717
$157,237
15K shares

Data source: SEC Form 13F-HR filings. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →

Insider Transactions

Sourced from SEC EDGAR Form 4 filings. Updated hourly.

DateInsiderCompanyTypeSharesPriceValue
Jun 4, 2026Ryan BarbaraINKT
Sale
1,000$12.80$13K
Jun 4, 2026Ryan BarbaraINKT
Sale
500$12.68$6K
Jun 1, 2026Behner PeterINKT
Award
1,313$12.38$16K
Jun 1, 2026Corvese BrianINKT
Award
1,444$12.38$18K
Jun 1, 2026WIINBERG ULFINKT
Award
1,131$12.38$14K

45 more transactions hidden

Free account · No credit card required

Building something? Get API access →

Popular companies on Form4API

Browse insider trading activity for other actively-filed companies.